Patents by Inventor Markus Buchetics

Markus Buchetics has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10865416
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: December 15, 2020
    Assignees: Boehringer Ingelheim RCV GmbH & Co KG, Vaitdogen GmbH, Lonza Ltd.
    Inventors: Brigitte Gasser, Diethard Mattanovich, Markus Buchetics
  • Patent number: 10590427
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: March 17, 2020
    Assignees: Boehringer Ingelheim RCV GmbH & Co KG, Lonza Ltd., Validogen GmbH
    Inventors: Brigitte Gasser, Diethard Mattanovich, Markus Buchetics
  • Publication number: 20170044557
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 16, 2017
    Inventors: Brigitte Gasser, Diethard Mattanovich, Markus Buchetics
  • Publication number: 20170029827
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 2, 2017
    Inventors: Brigitte Gasser, Diethard Mattanovich, Markus Buchetics